Results
- Showing results for:
- Reset all filters
Search results
-
Conference paperGhani R, Gan C, Mullish BH, et al., 2019, , British Association of Urological Surgeons Annual Scientific Meeting, Publisher: SAGE Publications, Pages: 83-85, ISSN: 2051-4158
-
Journal articleAllegretti JR, Kassam Z, Chiang AL, et al., 2019, , Gastroenterology, Vol: 156, Pages: S-129-S-129, ISSN: 0016-5085
-
Journal articleAllegretti JR, Hurtado J, Carrellas M, et al., 2019, , Gastroenterology, Vol: 156, Pages: S-2-S-3, ISSN: 0016-5085
-
Journal articleChurchward MA, Michaud ER, Blanco JM, et al., 2019, , Gastroenterology, Vol: 156, Pages: S-455-S-455, ISSN: 0016-5085
-
Journal articleMcDonald JA, Perez JL, Mullish BH, et al., 2019, , Gastroenterology, Vol: 156, Pages: S-898-S-898, ISSN: 0016-5085
-
Journal articleAbdul Rahim MBH, Chilloux J, Martinez-Gili L, et al., 2019, , Acta Diabetologica, Vol: 56, Pages: 493-500, ISSN: 0940-5429
The human gut is a home for more than 100 trillion bacteria, far more than all other microbial populations resident on the body's surface. The human gut microbiome is considered as a microbial organ symbiotically operating within the host. It is a collection of different cell lineages that are capable of communicating with each other and the host and has an ability to undergo self-replication for its repair and maintenance. As the gut microbiota is involved in many host processes including growth and development, an imbalance in its ecological composition may lead to disease and dysfunction in the human. Gut microbial degradation of nutrients produces bioactive metabolites that bind target receptors, activating signalling cascades, and modulating host metabolism. This review covers current findings on the nutritional and pharmacological roles of selective gut microbial metabolites, short-chain fatty acids, methylamines and indoles, as well as discussing nutritional interventions to modulate the microbiome.
-
Conference paperGhani R, Gan C, Mullish B, et al., 2019, , AUA 2019, Publisher: Elsevier, ISSN: 0022-5347
-
Journal articleAhmed B, Cox M, Cuthbertson L, et al., 2019, , Scientific Reports, Vol: 9, ISSN: 2045-2322
The pathogenesis of airway infection in cystic fibrosis (CF) is poorly understood. We performed a longitudinal study coupling clinical information with frequent sampling of the microbiota to identify changes in the airway microbiota in infancy that could underpin deterioration and potentially be targeted therapeutically. Thirty infants with CF diagnosed on newborn screening (NBS) were followed for up to two years. Two hundred and forty one throat swabs were collected as a surrogate for lower airway microbiota (median 35 days between study visits) in the largest longitudinal study of the CF oropharyngeal microbiota. Quantitative PCR and Illumina sequencing of the 16S rRNA bacterial gene were performed. Data analyses were conducted in QIIME and Phyloseq in R. Streptococcus spp. and Haemophilus spp. were the most common genera (55% and 12.5% of reads respectively) and were inversely related. Only beta (between sample) diversity changed with age (Bray Curtis r2 = 0.15, P = 0.03). Staphylococcus and Pseudomonas were rarely detected. These results suggest that Streptococcus spp. and Haemophilus spp., may play an important role in early CF. Whether they are protective against infection with more typical CF micro-organisms, or pathogenic and thus meriting treatment needs to be determined.
-
Conference paperOvadia C, Perdones-Montero A, Mullish B, et al., 2019,
Ursodeoxycholic acid treatment of cholestatic pregnancy can alter the gut microbiota to enhance bile acid modification and production of metabolically-active secondary bile acids - an explanation for 'responders' and 'non-responders'?
, Publisher: WILEY, Pages: 17-17, ISSN: 1470-0328 -
Journal articleMcilroy JR, Segal JP, Mullish BH, et al., 2019, , Human Microbiome Journal, Vol: 11, Pages: 100045-100045, ISSN: 2452-2317
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.
General enquiries
For any enquiries about the Microbiome Network at 911今日黑料, please contact: